Skip to content

This promotional website has been developed and funded by Recordati Rare Diseases and is only intended for healthcare professionals based in the UK and Ireland.
Prescribing Information (PI) and Adverse Event (AE) Reporting Information can be accessed via the links found at the bottom of this page.

  • Therapy Area
    • Cystinosis
    • Castleman Disease
    • Endocrinology
    • MF-CTCL
    • Neuroblastoma
    • Renal Cell Carcinoma (RCC)
  • Resources
  • Events

Filter content by therapy areas:

  • Castleman Disease
  • Cystinosis
  • Endocrinology
  • MF-CTCL
  • Renal Cell Carcinoma (RCC)

For prescribing and adverse event reporting information, click the links here: Cystadrops® (mercaptamine hydrochloride) | Cystagon® (mercaptamine bitartrate) | Fotivda® (tivozanib) | Isturisa® (osilodrostat) UK ONLY | Isturisa® (osilodrostat) IRELAND ONLY | Ledaga® (chlormethine) | Qarziba®▼ (dinutuximab beta) | Signifor® (pasireotide) | Sylvant®▼ (siltuximab)


Terms of Use, Privacy Policy & Cookie Policy
®2025 Recordati Rare Diseases. All rights reserved | IE-NPS-0232 June 2026

Login to RRDCampus

Not a member? Create account

Forgot password?

RRD Campus is a promotional website intended for UK & Ireland healthcare professionals.

Please confirm that you a healthcare professional based in the UK or Ireland by clicking below:

Decline

Login to RRDCampus

Not a member? Create account

Forgot password?

Please select the therapy areas you are interested in. These can be updated later in your profile.

Castleman Disease
Cystinosis
Endocrinology (Acromegaly & Cushing's Syndrome)
Mycosis Fungoides-type Cutaneous T-Cell Lymphoma (MF-CTCL)
Neuroblastoma
Renal Cell Carcinoma (RCC)
Already a member? Login here

You are now leaving the RRD Campus website.
RRD is not responsible for the content outside of RRDCampus.

 By clicking “continue” below, you will be taken to an external website.

 

Continue

Please register or login to access this material.

Register Login

This resource can now be accessed within the 'Saved Content' section of your profile.